Showing all 2 results
Neostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Neostigmine Bromide Ph.Eur./USP 15 mg Global Clinical Standard: Base therapeutic oral unit for the continuous, meticulously spaced symptomatic management of Myasthenia Gravis. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically for rapid, predictable gastric dissolution to ensure precise symptom control within 30 to 45 minutes of ingestion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic neurology dispensing, as patients may require up to 10-15 tablets per day in divided doses).
Salbutamol and Theophylline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Salbutamol Sulphate BP/Ph.Eur. 2 mg (Equivalent to Salbutamol base) Rapid-onset beta-2 agonism for immediate smooth muscle relaxation. Theophylline (Anhydrous) BP/Ph.Eur. 100 mg Global Clinical Standard: PDE inhibition for sustained bronchodilation and mild respiratory anti-inflammation. Excipients Microcrystalline Cellulose / Maize Starch / Purified Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered for strict, synchronized gastric dissolution) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-compliance 30-day chronic pulmonology dispensing regimens).
